{
  "trial_id": "NCT02849184",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Sex, Treatment classification, Antihypertensive medication status, Clinic systolic blood pressure (SBP), Insomnia symptoms (difficulty initiating sleep, difficulty maintaining sleep, early morning awakening, difficulty sleeping deeply), Interference with social or occupational function due to insomnia, Serious liver disease status, Serious respiratory disease status, Secondary hypertension status, Sleep apnea syndrome status, History of narcolepsy or cataplexy, History of organic cerebral disorders, History of hypersensitivity to suvorexant, Use of CYP3A strongly-inhibitors, Average clinic SBP, Use of suvorexant and other hypnotics, Breast-feeding status, Pregnancy status, Investigator's eligibility assessment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex"
        ],
        [
          "Nighttime systolic blood pressure",
          "Clinic systolic blood pressure (SBP)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "BMI",
        "Nighttime diastolic blood pressure"
      ],
      "remaining_candidate_features": [
        "Treatment classification",
        "Antihypertensive medication status",
        "Insomnia symptoms (difficulty initiating sleep, difficulty maintaining sleep, early morning awakening, difficulty sleeping deeply)",
        "Interference with social or occupational function due to insomnia",
        "Serious liver disease status",
        "Serious respiratory disease status",
        "Secondary hypertension status",
        "Sleep apnea syndrome status",
        "History of narcolepsy or cataplexy",
        "History of organic cerebral disorders",
        "History of hypersensitivity to suvorexant",
        "Use of CYP3A strongly-inhibitors",
        "Average clinic SBP",
        "Use of suvorexant and other hypnotics",
        "Breast-feeding status",
        "Pregnancy status",
        "Investigator's eligibility assessment."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Insomnia Severity Index, Duration of Insomnia, Use of Antihypertensive Medications, Use of Sleep Medications,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "BMI",
          "Body Mass Index"
        ],
        [
          "Nighttime systolic blood pressure",
          "Systolic Blood Pressure"
        ],
        [
          "Nighttime diastolic blood pressure",
          "Diastolic Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Insomnia Severity Index",
        "Duration of Insomnia",
        "Use of Antihypertensive Medications",
        "Use of Sleep Medications"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, History of Hypertension, History of Insomnia, Antihypertensive Medication Use,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "BMI",
          "Body Mass Index"
        ],
        [
          "Nighttime systolic blood pressure",
          "Systolic Blood Pressure"
        ],
        [
          "Nighttime diastolic blood pressure",
          "Diastolic Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "History of Hypertension",
        "History of Insomnia",
        "Antihypertensive Medication Use"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, treatment classification, clinic systolic blood pressure, antihypertensive medication use, insomnia symptoms, social or occupational function interference, morning home systolic blood pressure, liver disease history, respiratory disease history, secondary hypertension history, sleep apnea syndrome history, narcolepsy or cataplexy history, organic cerebral disorders history, hypersensitivity to suvorexant history, CYP3A strongly-inhibitors use, pregnancy status, breastfeeding status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Nighttime systolic blood pressure",
          "clinic systolic blood pressure"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "BMI",
        "Nighttime diastolic blood pressure"
      ],
      "remaining_candidate_features": [
        "treatment classification",
        "antihypertensive medication use",
        "insomnia symptoms",
        "social or occupational function interference",
        "morning home systolic blood pressure",
        "liver disease history",
        "respiratory disease history",
        "secondary hypertension history",
        "sleep apnea syndrome history",
        "narcolepsy or cataplexy history",
        "organic cerebral disorders history",
        "hypersensitivity to suvorexant history",
        "CYP3A strongly-inhibitors use",
        "pregnancy status",
        "breastfeeding status"
      ]
    }
  }
}